(Q39249833)

10 September 2017

title

Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection (English)

1 reference

dengue virus envelope protein

10 September 2017

1 reference

1 reference

based on heuristic

inferred from abstract

post-translational protein modification

0 references

Dominique Schols

0 references

Johan Neyts

0 references

Jan Balzarini

1 reference

10 September 2017

Marijke M F Alen

1 reference

10 September 2017

Kai Dallmeier

series ordinal

1 reference

10 September 2017

language of work or name

1 reference

31 October 2012

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

280-287

1 reference

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

10 September 2017

cites work

2 references

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/S0092-8674(00)80694-7

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

New low-viscosity overlay medium for viral plaque assays

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

A ligand-binding pocket in the dengue virus envelope glycoprotein

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Inhibition of dengue virus by targeting viral NS4B protein

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

A variant in the CD209 promoter is associated with severity of dengue disease

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Replication in cells of hematopoietic origin is necessary for Dengue virus dissemination

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Dengue and dengue hemorrhagic fever

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

High fidelity of yellow fever virus RNA polymerase

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Both E protein glycans adversely affect dengue virus infectivity but are beneficial for virion release

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Pathogenesis of liver involvement during dengue viral infections

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Molecular strategies to inhibit the replication of RNA viruses

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

A method for full genome sequencing of all four serotypes of the dengue virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Biological Significance of Glycosylation of the Envelope Protein of Kunjin Virus

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Virus glycosylation: role in virulence and immune interactions

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain).

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Broad antiviral activity of carbohydrate-binding agents against the four serotypes of dengue virus in monocyte-derived dendritic cells

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Essential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral Propagation

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Human skin Langerhans cells are targets of dengue virus infection

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Biosynthesis, primary structure and molecular cloning of snowdrop (Galanthus nivalis L.) lectin

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Dengue virus life cycle: viral and host factors modulating infectivity

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Inhibition of Dengue Virus through Suppression of Host Pyrimidine Biosynthesis

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Isolation and characterization of a lectin with exclusive specificity towards mannose from snowdrop (Galanthus nivalis ) bulbs

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN.

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Pradimicin S, a new pradimicin analog. II. Isolation and structure elucidation

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

3 November 2022

Protein glycosylation

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

Monocyte-derived dendritic cells have a phenotype comparable to that of dermal dendritic cells and display ultrastructural granules distinct from Birbeck granules

3 November 2022

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2012.10.007

10.1016/J.ANTIVIRAL.2012.10.007

3 November 2022

Identifiers

DOI

1 reference

10 September 2017

1 reference